Clinical, endocrinological and radiological features in a child with McCune-Albright syndrome and pituitary adenoma

Journal of Pediatric Endocrinology and Metabolism

Volumn 14, Issue 5, 2001, Pages 553-559

  Zumkeller, Walter ^a,b   Jassoy, André ^a   Lebek, Susanne ^a   Nagel, Matthias ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Fibrous dysplasia; Hyperthyroidism; McCune Albright syndrome; Pituitary adenoma

Indexed keywords

BROMOCRIPTINE; OCTREOTIDE; PAMIDRONIC ACID; PROLACTIN; THIAMAZOLE; THYROID HORMONE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BISPHOSPHONIC ACID DERIVATIVE;

ADULT; ALBRIGHT SYNDROME; ARTICLE; BONE SCINTISCANNING; CAFE AU LAIT SPOT; CASE REPORT; CHILD; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; ENDOCRINE DISEASE; ENDOCRINOLOGY; HORMONE DETERMINATION; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS ADENOMA; IMAGE RECONSTRUCTION; MALE; MOBILIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRECOCIOUS PUBERTY; RADIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; WHOLE BODY SCINTISCANNING; ADENOMA; DRUG COMBINATION; ENDOCRINE GLAND; HYPOPHYSIS TUMOR; IMAGE PROCESSING; PATHOPHYSIOLOGY; SCINTISCANNING;

ADENOMA; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; CHILD; DIPHOSPHONATES; DRUG THERAPY, COMBINATION; ENDOCRINE GLANDS; FIBROUS DYSPLASIA, POLYOSTOTIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; OCTREOTIDE; PITUITARY NEOPLASMS; RADIOGRAPHY; RADIONUCLIDE IMAGING; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0035005559     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2001.14.5.553     Document Type: Article

References (34)

1. Ringel MD, Schwindinger WF, Levine MA. Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy. Medicine 1996; 75: 171-184.
2. Spiegel AM. The molecular basis of disorders caused by defects in G proteins. Horm Res 1997; 47: 89-96.
3. Albright F, Butler AM, Hampton AO, Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction with precocious puberty in females: report of five cases. N Engl J Med 1937; 216: 727-746.
4. McCune D, Bruch H. Osteodystrophia fibrosa. Report of a case in which the condition was combined with precocious puberty, pathologic pigmentation of the skin, and hyperthyroidism with review of the literature. Am J Dis Child 1937; 54: 806.
5. Cavanah SF, Dons RF. McCune-Albright syndrome: how many endocrinopathies can one patient have? Southern Med J 1993; 86: 364-367.
6. Abs R, Beckers A, Van de Vyver FL, De Schepper A, Stevenaert A, Hennen G. Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia. A variant of the McCune-Albright syndrome. J Endocrinol Invest 1990; 13: 671-675.
7. Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, Boney CM, van Wyk JJ, Meriono MJ, Feuillan PP, Spiegel AM. Severe endocrine and non-endocrine manifestations of the McCune-Albright syndrome associated with activating mutations of the stimulatory G protein Gs. J Pediatr 1993; 123: 509-518.
8. Daly BD, Chow CC, Cockram CS. Unusual manifestation of craniofacial fibrous dysplasia: clinical, endocrinological and computed tomographic features. Postgrad Med J 1994; 70: 10-16.
9. Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 1992; 89: 5152-5156.
10. Shenker A, Weinstein LS, Sweet DE, Spiegel AM. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metabol 1994; 79: 750-755.
11. Gessl A, Freissmuth M, Czech T, Matula C, Hainfellner JA, Buchfelder M, Vierhapper H. Growth hormone-prolactin-thyrotropin-secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gs alpha protein. J Clin Endocrinol Metab 1994; 79: 1128-1134.
12. Motomura T, Kasayama S, Takagi M, Kurebayashi S, Matsui H, Hirose T, Miyashita Y, Yamauchi-Takihara K, Yamamoto T, Okada S, Kishimoto T. Increased interleukin-6 production in mouse osteoblastic MC3T3-E1 cells expressing activating mutant of the stimulatory G protein. J Bone Miner Res 1998; 13: 1084-1091.
13. Candeliere GA, Glorieux FH, Prud'homme J, St Arnaud R. Increased expression of the c-fos protooncogene in bone from patients with fibrous dysplasia. N Engl J Med 1995; 332: 1546-1551.
14. Pfeffer S, Molina E, Feuillan P, Simon TR. McCune-Albright syndrome: the patterns of scintigraphic abnormalities. J Nucl Med 1990; 31: 1474-1478.
15. Yamamoto T, Ozono K, Kasayama S, Yoh K, Hiroshima K, Takagi M, Matsumoto S, Michigami T, Yamaoka K, Kishimoto T, Okada S. Increased IL-6 production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. J Clin Invest 1996; 98: 30-35.
16. Roodman GD, Kurihara N, Ohsaki Y, Kukita A, Hosking D, Demulder A, Smith JF, Singer FR. Interleukin-6: a potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest 1992; 89: 46-52.
17. Riminucci M, Fisher LW, Shenker A, Spiegel AM, Bianco P, Gehron-Robey P. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 1997; 151: 1587-1600.
18. Pfeilschifter J, Ziegler R. Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright syndrome. Med Klin 1998; 93: 352-359.
19. Chapurlat RD, Delmas PD, Liens D, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 1997; 12: 1746-1752.
20. Lair-Milan F, Blevec GL, Carel JC, Chaussain JL, Adamsbaum C. Thyroid sonographic abnormalities in McCune-Albright syndrome. Pediatr Radiol 1996; 26: 424-426.
21. Machida K, Makita K, Nishikawa J, Ohtake T, Iio M. Scintigraphic manifestations of fibrous dysplasia. Clin Nucl Med 1986; 11: 426-429.
22. Johns WD, Gupta SM, Kayani N. Scintigraphic evaluation of polyostotic fibrous dysplasia. Clin Nucl Med 1987; 12: 627-631.
23. Inamo Y, Hanawa Y, Kin H, Okuni M. Findings of magnetic resonance imaging of the spine and femur in a case of McCune-Albright syndrome. Pediatr Radiol 1993; 23: 15-18.
24. Sener RN. An extensive type of polyostotic fibrous dysplasia. Pediatr Radiol 1997; 27: 339-341.
25. Kairemo KJA, Verho S, Dunkel L. Imaging of McCune-Albright syndrome using bone single photon emission computed tomography. Eur J Pediatr 1999; 158: 123-126.
26. O'Laughlin RL, Selinger SE, Moriarty PE. Pituitary adenoma in McCune-Albright syndrome: MR demonstration. J Comput Assist Tomogr 1989; 13: 685-688.
27. Cremonini N, Graziano E, Chiarini V, Sforza A, Zampa GA. Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995-bromocriptine combined treatment results. J Clin Endocrinol Metab 1992; 75: 1166-1169.
28. Feuillan PP, Jones J, Ross JL. Growth hormone hypersecretion in a girl with McCune-Albright syndrome: comparison with controls and response to a dose of long-acting somatostatin analog. J Clin Endocrinol Metab 1995; 80: 1357-1360.
29. Chanson P, Dib A, Visot A, Derome PJ. McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases. Eur J Endocrinol 1994; 131: 229-234.
30. Tolis G. The role of somatostatin agonistic analogs in the treatment of acromegaly. Metabolism 1996; 45 (Suppl 1): 109-110.
31. Bocca G, de Vries J, Cruysberg JR, Boers GH, Monnens LA. Optic neuropathy in McCune-Albright syndrome: an indication for aggressive treatment. Acta Paediatr 1998; 87: 599-600.
32. Ruggieri P, Sim FH, Bond JR, Unni KK. Malignancies in fibrous dysplasia. Cancer 1994; 73: 1411-1424.
33. Ozaki T, Lindner N, Blasius S. Dedifferentiated chondrosarcoma in Albright syndrome. J Bone Joint Surg-Amer 1997; 79: 1545-1551.
34. Viljoen DL, Versfeld GA, Losken W, Beighton P. Polyostotic fibrous dysplasia with cranial hyperostosis: new entity or most severe form of polyostotic fibrous dysplasia? Am J Med Genet 1988; 29: 661-667.